MCID: LVR002
MIFTS: 45

Liver Angiosarcoma malady

Categories: Rare diseases, Cancer diseases, Gastrointestinal diseases, Liver diseases

Aliases & Classifications for Liver Angiosarcoma

About this section

Aliases & Descriptions for Liver Angiosarcoma:

Name: Liver Angiosarcoma 10 12
Angiosarcoma of Liver 10 65
 
Hemangiosarcoma of the Liver 10
Angiosarcoma of the Liver 45

Classifications:



External Ids:

Disease Ontology10 DOID:268
ICD1027 C22.3
NCIt42 C4438
UMLS65 C0345907

Summaries for Liver Angiosarcoma

About this section
Disease Ontology:10 An angiosarcoma and sarcoma of liver and hemangioma of intra-abdominal structure and Ca liver - primary that is located in the liver.

MalaCards based summary: Liver Angiosarcoma, also known as angiosarcoma of liver, is related to myh9-related disorders and ovary neuroendocrine neoplasm. An important gene associated with Liver Angiosarcoma is KRAS (Kirsten Rat Sarcoma Viral Oncogene Homolog), and among its related pathways are MNAR-PELP1 and Estrogen Receptor Interaction and CD209 (DC-SIGN) signaling. Affiliated tissues include the liver, liver and breast, and related mouse phenotypes are digestive/alimentary and no phenotypic analysis.

Related Diseases for Liver Angiosarcoma

About this section

Diseases related to Liver Angiosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 131)
idRelated DiseaseScoreTop Affiliating Genes
1myh9-related disorders10.5KRAS, TP53
2ovary neuroendocrine neoplasm10.5KRAS, TP53
3pyridoxal 5'-phosphate-dependent epilepsy10.5KRAS, TP53
4familial hemangioma10.5CYP2E1, VWF
5benign mesenchymoma10.5KRAS, TP53
6white piedra10.5CYP2E1, TP53
7intracranial sinus thrombosis10.5KRAS, TP53
8reproductive organ benign neoplasm10.5ENO2, KRAS
9common bile duct disease10.4TP53, VWF
10dermato-cardio-skeletal syndrome, borrone type10.4TP53, VWF
11corneal edema10.4CYP2E1, TP53
12angiolipoma10.4CDK4, VWF
13tetrasomy 12p10.4HRAS, KRAS
14sigmoid disease10.4HRAS, KRAS
15diabetic encephalopathy10.4HRAS, KRAS
16adult central nervous system mixed germ cell tumor10.4KRAS, TP53
17epidermal nevus, somatic10.4HRAS, KRAS
18chronic inflammatory demyelinating polyradiculoneuropathy10.4HRAS, KRAS
19schimmelpenning-feuerstein-mims syndrome, somatic mosaic10.4HRAS, KRAS
20syphilis10.4ENO2, TP53
21mucosal melanoma10.4HRAS, KRAS
22chronic rhinitis10.4ENO2, TP53
23eccrine papillary adenocarcinoma10.4HRAS, KRAS
24erythrasma10.4HRAS, KRAS
25precursor lymphoblastic lymphoma/leukemia10.4HRAS, KRAS
26ovarian serous cystadenocarcinoma10.4HRAS, KRAS
27scabies10.4ENO2, TP53
28myelofibrosis10.4HRAS, KRAS
29sweat gland cancer10.3HRAS, KRAS
30neuromuscular disease10.3HRAS, KRAS
31corneal neovascularization10.3ENO2, TP53
32anterior horn cell disease10.3HRAS, KRAS
33pyelonephritis10.3ENO2, TP53
34ovarian mucinous adenocarcinoma10.3HRAS, KRAS
35renal artery obstruction10.3ENO2, TP53
36prion disease10.3CDK4, TP53
37migraine with aura10.3HRAS, KRAS
38malignant giant cell tumor of soft parts10.3HRAS, KRAS
39pneumonic plague10.3HRAS, KRAS
40malignant fibroxanthoma10.3HRAS, KRAS
41serous surface papilloma10.3HRAS, KRAS
42corticosterone methyloxidase deficiency10.3HRAS, KRAS
43angiosarcoma10.3
44colonic l-cell glucagon-like peptide producing tumor10.3ENO2, TP53
45punctate acrokeratoderma freckle like pigmentation10.3HRAS, KRAS
46merrf syndrome10.3CDK4, TP53
47gallbladder leiomyosarcoma10.3HRAS, KRAS
48splenogonadal fusion limb defects micrognatia10.3HRAS, TP53
49adult medulloblastoma10.3ENO2, TP53
50cavernous hemangioma10.3HRAS, KRAS

Graphical network of the top 20 diseases related to Liver Angiosarcoma:



Diseases related to liver angiosarcoma

Symptoms for Liver Angiosarcoma

About this section

Drugs & Therapeutics for Liver Angiosarcoma

About this section

Drugs for Liver Angiosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxorubicinapproved, investigationalPhase 3, Phase 1158223214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
2
IfosfamideapprovedPhase 33713778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide
 
Ifosfamide (JAN/USP/INN)
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
3
DoxilApproved June 1999Phase 3, Phase 1158231703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
4Topoisomerase InhibitorsPhase 3, Phase 14081
5Antibiotics, AntitubercularPhase 3, Phase 2, Phase 15971
6Anti-Bacterial AgentsPhase 3, Phase 2, Phase 19140
7Alkylating AgentsPhase 33582
8Antineoplastic Agents, AlkylatingPhase 33406
9Isophosphamide mustardPhase 3371
10
GemcitabineapprovedPhase 2188195058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine Hydrochloride
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
11Immunologic FactorsPhase 218483
12Immunosuppressive AgentsPhase 210422
13AntimetabolitesPhase 29454
14Anti-Infective AgentsPhase 217220
15Antimetabolites, AntineoplasticPhase 25770
16Antiviral AgentsPhase 28071
17
RomidepsinPhase 281128517-07-75352062
Synonyms:
(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
128517-07-7
AC1NS1N3
Antibiotic FR 901228
C087123
C24H36N4O6S2
CHEBI:61080
CHEMBL343448
CID5352062
Chromadax
Chromadax (TN)
Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (3?5)-disulfide"
D06637
FK 228
 
FK-228
FK-901228
FK228
FR 901228
FR-901228
FR901228
HDInhib_000006
Istodax
L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide
LS-161318
NSC 630176
NSC-630176
NSC630176
Probes1_000153
Probes2_000337
Romidepsin
Romidepsin (USAN)
nchembio.313-comp2
18ImmunoglobulinsPhase 14477
19Antibodies, MonoclonalPhase 12413
20AntibodiesPhase 14477
21Liver Extracts3572

Interventional clinical trials:

idNameStatusNCT IDPhase
1Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaActive, not recruitingNCT00346164Phase 3
2Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1, Phase 2
3Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue SarcomaRecruitingNCT01532687Phase 2
4Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaActive, not recruitingNCT00112463Phase 2
5Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00720174Phase 1
6Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasCompletedNCT01567046
7Identification, Molecular Epidemiology Angiosarcoma of the Liver FranceRecruitingNCT01786889

Search NIH Clinical Center for Liver Angiosarcoma

Genetic Tests for Liver Angiosarcoma

About this section

Anatomical Context for Liver Angiosarcoma

About this section

MalaCards organs/tissues related to Liver Angiosarcoma:

33
Liver, Breast, Prostate, Ovary, Monocytes, T cells, Testes

FMA organs/tissues related to Liver Angiosarcoma:

16
The liver

Animal Models for Liver Angiosarcoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Liver Angiosarcoma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.1CDK4, KRAS, KRT19, TP53, VWF
2MP:00030128.1HRAS, KRAS, KRT19, TP53, VWF
3MP:00107718.0CDK4, HRAS, KRAS, KRT19, TP53
4MP:00020067.7CDK4, CYP2E1, HRAS, KRAS, KRT19, TP53
5MP:00107686.9CDK4, CYP2E1, HRAS, KRAS, KRT19, TP53
6MP:00053856.9CDK4, CYP2E1, HRAS, KRAS, KRT19, TP53
7MP:00036316.9CDK4, ENO2, HRAS, KRAS, KRT19, TP53

Publications for Liver Angiosarcoma

About this section

Articles related to Liver Angiosarcoma:

(show all 16)
idTitleAuthorsYear
1
Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case report. (22280556)
2012
2
Widening spectrum of liver angiosarcoma in children. (21832953)
2011
3
Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride. (12211074)
2002
4
Liver angiosarcoma and hemangiopericytoma after occupational exposure to vinyl chloride monomer. (10964802)
2000
5
Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma. (10952247)
2000
6
Diffuse liver angiosarcoma and cerebral cavernous angiomas in a young patient. (10692780)
1999
7
Two new cases of liver angiosarcoma: history and perspectives of liver angiosarcoma among plastic industry workers. (9284534)
1997
8
Vinylchloride monomer exposure by the plastic industry workers basic condition for liver angiosarcoma appearance. (9277092)
1996
9
Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. (1793483)
1991
10
Invasive character of malignant endothelial cells in vinyl-chloride-induced liver angiosarcoma. (2381457)
1990
11
Massive bleeding after fine needle aspiration of liver angiosarcoma. (2298353)
1990
12
Liver angiosarcoma in a vinyl chloride polymerization plant worker. Report of the seventh Italian case. (3173221)
1988
13
Iatrogenic disease. Lipoid pneumonia and liver angiosarcoma. (3714604)
1986
14
Two cases of liver angiosarcoma among polyvinyl chloride (PVC) extruders of an Italian factory producing PVC bags and other containers. (6539068)
1984
15
Log normal distribution of the incubation period of liver angiosarcoma in vinyl chloride polymerization workers. (569691)
1979
16
Persistence of DNA damage during development of liver angiosarcoma in rats fed dimethylnitrosamine. (570883)
1979

Variations for Liver Angiosarcoma

About this section

Expression for genes affiliated with Liver Angiosarcoma

About this section
Search GEO for disease gene expression data for Liver Angiosarcoma.

Pathways for genes affiliated with Liver Angiosarcoma

About this section

Pathways related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

(show all 42)
idSuper pathwaysScoreTop Affiliating Genes
19.5HRAS, KRAS
29.5HRAS, KRAS
3
Show member pathways
9.5HRAS, KRAS
49.5HRAS, KRAS
59.5HRAS, KRAS
69.5HRAS, KRAS
79.5CDK4, TP53
89.5CDK4, TP53
99.2KRT19, TP53
10
Show member pathways
9.2CDK4, KRAS, TP53
119.2CDK4, KRAS, TP53
129.2CDK4, KRAS, TP53
13
Show member pathways
9.2CDK4, KRAS, TP53
149.1HRAS, KRAS, VWF
15
Show member pathways
9.1HRAS, KRAS, TP53
169.1HRAS, KRAS, TP53
179.1HRAS, KRAS, TP53
18
Show member pathways
9.1HRAS, KRAS, TP53
19
Show member pathways
9.1HRAS, KRAS, TP53
20
Show member pathways
9.1HRAS, KRAS, TP53
21
Show member pathways
9.1HRAS, KRAS, TP53
22
Show member pathways
9.1HRAS, KRAS, TP53
23
Show member pathways
9.1HRAS, KRAS, TP53
249.1HRAS, KRAS, TP53
259.1HRAS, KRAS, TP53
269.1HRAS, KRAS, TP53
279.1HRAS, KRAS, TP53
28
Show member pathways
9.1HRAS, KRAS, TP53
29
Show member pathways
9.1HRAS, KRAS, TP53
309.0CDK4, HRAS, KRAS
31
Show member pathways
9.0CDK4, HRAS, KRAS
329.0CDK4, HRAS, KRAS
33
Show member pathways
8.9CDK4, HRAS, TP53
34
Show member pathways
8.5CDK4, HRAS, KRAS, TP53
358.5CDK4, HRAS, KRAS, TP53
368.5CDK4, HRAS, KRAS, TP53
37
Show member pathways
8.5CDK4, HRAS, KRAS, TP53
388.5CDK4, HRAS, KRAS, TP53
398.5CDK4, HRAS, KRAS, TP53
40
Show member pathways
8.5CDK4, HRAS, KRAS, TP53
418.5CDK4, HRAS, KRAS, TP53
428.1CDK4, HRAS, KRAS, TP53, VWF

GO Terms for genes affiliated with Liver Angiosarcoma

About this section

Biological processes related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ERBB2 signaling pathwayGO:00381289.5HRAS, KRAS
2social behaviorGO:00351769.5HRAS, KRAS
3cell agingGO:00075699.3HRAS, TP53
4regulation of long-term neuronal synaptic plasticityGO:00481699.2HRAS, KRAS

Sources for Liver Angiosarcoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet